Epidermal growth factor receptor (EGFR), another receptor tyrosine kinase, shows overexpression in up to 74% of bladder cancer specimens, as compared to the relatively low expression level seen in normal urothelium [125,126,127]. This evidence concerns the gene NTRK1 and urinary bladder cancer.